WGS
GeneDx Holdings Corp.
$59.92
-1.75%
$1.8B
No data for this timeframe.
Vol
Market Cap$1.8B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (92%)
Inst. Holders50 funds
Inst. Value$1.2B
Inst. Activity17 buys / 17 sells
Insider Activity14B / 15S
Insider Net $$52.2M
Reddit Sentiment58° Warm
SEC Reports6
Recent Activity
Jun 11, 2026
SEC
A small institutional cluster of 5 buyers accumulated $15.3M in net new GeneDx stock during Q3 2024, led by Schwab and P
INST-CLUSTER — Impact 4/10
Jun 9, 2026
Insider
Stueland Katherine acquired via exercise 6,546 shares
CHIEF EXECUTIVE OFFICER
Jun 9, 2026
Insider
Stueland Katherine sold 3,639 shares
CHIEF EXECUTIVE OFFICER @ $53.77 ($195.7K)
Jun 9, 2026
Insider
Feeley Kevin acquired via exercise 2,462 shares
CHIEF FINANCIAL OFFICER
Jun 8, 2026
SEC
GeneDx Holdings Corp. (WGS) insiders show a mixed cluster: Director/10% owner Casdin Capital made a large open-market pu
CLUSTER — Impact 6/10
May 20, 2026
SEC
Two large-position insiders at GeneDx (WGS) — Casdin Capital (a director/10% owner) and director Keith Meister — purchas
CLUSTER — Impact 6/10
Inst.
ARK Investment Management LLC — DOUBLED
1,324,583 shares ($85.1M)
Inst.
Sumitomo Mitsui Trust Group, — ADD
633,457 shares ($40.7M)
Price Targets
$77.00
+28.5% upside
Strong Buy
Current $59.92
Low $50.00
Median $75.00
High $100.00
9 analysts
$50.00
$100.00
Analyst Ratings
4Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 5, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 5, 2026 | Wells Fargo | MAINTAIN | Overweight → Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy → Buy |
| May 5, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.19 ▼ -262.0% | $-0.30 — $-0.16 | -138% YoY | 8 |
| Next Q | $0.12 ▼ -67.5% | $-0.15 — $0.21 | -77% YoY | 8 |
| Current FY | $0.11 ▼ -87.9% | $-0.69 — $1.38 | -92% YoY | 8 |
| Next FY | $1.23 ▼ -40.1% | $0.41 — $2.37 | 1019% YoY | 8 |
Latest Reports
BULLISH
INST-CLUSTER
4/10
A small institutional cluster of 5 buyers accumulated $15.3M in net new GeneDx stock during Q3 2024, led by Schwab and P
Jun 11, 2026
BULLISH
CLUSTER
6/10
GeneDx Holdings Corp. (WGS) insiders show a mixed cluster: Director/10% owner Casdin Capital made a large open-market pu
Jun 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Corvex Management LP | $207.3M | — |
| BlackRock, Inc. | $99.6M | — |
| GOLDMAN SACHS GROUP INC | $85.7M | — |
| ARK Investment Management LLC | $85.1M | DOUBLED |
| VANGUARD CAPITAL MANAGEMENT LLC | $55.1M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 9, 2026 | Stueland Katherine | M | $0.00 |
| Jun 9, 2026 | Stueland Katherine | SELL | $195.7K |
| Jun 9, 2026 | Feeley Kevin | M | $0.00 |
| Jun 9, 2026 | Feeley Kevin | SELL | $68.1K |
| Jun 5, 2026 | Casdin Capital, | BUY | $2.6M |
Reddit Sentiment
58°
Warm
Bearish
Neutral
Bullish
50 institutional holders with $1.2B total value (18,121,942 shares) as of 2026-Q1. Top holders: Corvex, BlackRock,, GOLDMAN.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Corvex Management LP | 3,228,149 | $207.3M | 17.8% | — |
| 2 | BlackRock, Inc. | 1,550,708 | $99.6M | 8.6% | — |
| 3 | GOLDMAN SACHS GROUP INC | 1,334,980 | $85.7M | 7.4% | — |
| 4 | ARK Investment Management LLC | 1,324,583 | $85.1M | 7.3% | DOUBLED +119.1% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 858,583 | $55.1M | 4.7% | — |
| 6 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 775,269 | $49.8M | 4.3% | TRIM -33.7% |
| 7 | CITADEL ADVISORS LLC | 647,401 | $41.6M | 3.6% | — |
| 8 | Sumitomo Mitsui Trust Group, Inc. | 633,457 | $40.7M | 3.5% | ADD +65.9% |
| 9 | FRANKLIN RESOURCES INC | 607,221 | $39.0M | 3.3% | TRIM -44.4% |
| 10 | RAYMOND JAMES FINANCIAL INC | 610,073 | $38.8M | 3.3% | — |
| 11 | Invesco Ltd. | 540,229 | $34.7M | 3.0% | TRIM -31.3% |
| 12 | MORGAN STANLEY | 532,235 | $34.2M | 2.9% | — |
| 13 | STATE STREET CORP | 472,445 | $30.3M | 2.6% | — |
| 14 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 358,978 | $23.1M | 2.0% | ADD +80.5% |
| 15 | WELLINGTON MANAGEMENT GROUP LLP | 341,005 | $21.9M | 1.9% | — |
| 16 | Capital International Investors | 324,588 | $20.8M | 1.8% | DOUBLED +182.4% |
| 17 | FMR LLC | 295,621 | $19.0M | 1.6% | TRIM -64.5% |
| 18 | DIMENSIONAL FUND ADVISORS LP | 265,791 | $17.1M | 1.5% | DOUBLED +143.4% |
| 19 | BANK OF AMERICA CORP /DE/ | 234,606 | $15.1M | 1.3% | ADD +77.5% |
| 20 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 221,245 | $14.2M | 1.2% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| ARK Investment Management LLC | DOUBLED | 604,561 | 1,324,583 | +119.1% | $85.1M | 2026-Q1 |
| Sumitomo Mitsui Trust Group, Inc. | ADD | 381,725 | 633,457 | +65.9% | $40.7M | 2026-Q1 |
| FRANKLIN RESOURCES INC | TRIM | 1,092,988 | 607,221 | -44.4% | $39.0M | 2026-Q1 |
| Invesco Ltd. | TRIM | 786,466 | 540,229 | -31.3% | $34.7M | 2026-Q1 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | ADD | 198,926 | 358,978 | +80.5% | $23.1M | 2026-Q1 |
| FMR LLC | TRIM | 832,738 | 295,621 | -64.5% | $19.0M | 2026-Q1 |
| DIMENSIONAL FUND ADVISORS LP | DOUBLED | 109,188 | 265,791 | +143.4% | $17.1M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 132,150 | 234,606 | +77.5% | $15.1M | 2026-Q1 |
| RA CAPITAL MANAGEMENT, L.P. | DOUBLED | 58,044 | 209,887 | +261.6% | $13.5M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | ADD | 117,057 | 195,889 | +67.3% | $12.6M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 57,316 | 153,716 | +168.2% | $9.9M | 2026-Q1 |
| ROYCE & ASSOCIATES LP | ADD | 75,783 | 140,513 | +85.4% | $9.0M | 2026-Q1 |
| Rockefeller Capital Management L.P. | DOUBLED | 562 | 96,590 | +17086.8% | $6.2M | 2026-Q1 |
| Assenagon Asset Management S.A. | TRIM | 205,895 | 95,128 | -53.8% | $6.1M | 2026-Q1 |
| POLEN CAPITAL MANAGEMENT LLC | ADD | 59,861 | 77,419 | +29.3% | $5.0M | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | ADD | 58,458 | 77,369 | +32.3% | $5.0M | 2026-Q1 |
| VICTORY CAPITAL MANAGEMENT INC | DOUBLED | 26,975 | 63,505 | +135.4% | $4.1M | 2026-Q1 |
| ENVESTNET ASSET MANAGEMENT INC | DOUBLED | 18,182 | 46,377 | +155.1% | $3.0M | 2026-Q1 |
| Russell Investments Group, Ltd. | TRIM | 74,895 | 32,535 | -56.6% | $2.1M | 2026-Q1 |
| Vestmark Advisory Solutions, Inc. | ADD | 17,067 | 28,865 | +69.1% | $1.9M | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 41,041 | 21,824 | -46.8% | $1.4M | 2026-Q1 |
| SEI INVESTMENTS CO | TRIM | 36,869 | 17,660 | -52.1% | $1.1M | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 24,873 | 12,053 | -51.5% | $774.0K | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | ADD | 6,017 | 10,103 | +67.9% | $648.8K | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | TRIM | 8,800 | 6,100 | -30.7% | $391.7K | 2026-Q1 |
5 unique insiders with 50 transactions. Net insider value: $52.2M ($55.5M bought, $3.2M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | EXERCISE | 6,546 | — | — |
| Jun 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 3,639 | $53.77 | $195.7K |
| Jun 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 2,462 | — | — |
| Jun 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 1,266 | $53.77 | $68.1K |
| Jun 5, 2026 | Casdin Capital, LLC | Director | BUY | 50,000 | $52.86 | $2.6M |
| Jun 4, 2026 | Casdin Capital, LLC | Director | BUY | 150,000 | $56.44 | $8.5M |
| Jun 1, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 717 | — | — |
| Jun 1, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 369 | $51.74 | $19.1K |
| May 20, 2026 | Casdin Capital, LLC | Director | BUY | 140,000 | $43.81 | $6.1M |
| May 19, 2026 | Casdin Capital, LLC | Director | BUY | 185,000 | $42.60 | $7.9M |
| May 18, 2026 | Casdin Capital, LLC | Director | BUY | 175,000 | $42.55 | $7.4M |
| May 15, 2026 | Meister Keith A. | Director | BUY | 27,408 | $38.28 | $1.0M |
| May 14, 2026 | Meister Keith A. | Director | BUY | 88,107 | $39.08 | $3.4M |
| May 13, 2026 | Meister Keith A. | Director | BUY | 94,074 | $38.82 | $3.7M |
| May 11, 2026 | Casdin Capital, LLC | Director | BUY | 50,000 | — | — |
| May 11, 2026 | Meister Keith A. | Director | BUY | 246,734 | $38.91 | $9.6M |
| May 8, 2026 | Casdin Capital, LLC | Director | BUY | 300,000 | — | — |
| May 8, 2026 | Meister Keith A. | Director | BUY | 15,745 | $38.00 | $598.3K |
| May 7, 2026 | Casdin Capital, LLC | Director | BUY | 500,000 | — | — |
| May 7, 2026 | Meister Keith A. | Director | BUY | 128,181 | $35.46 | $4.5M |
| Apr 29, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 392 | $65.19 | $25.6K |
| Apr 29, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 754 | — | — |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | EXERCISE | 3,874 | — | — |
| Apr 29, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 2,154 | $65.20 | $140.4K |
| Mar 26, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | EXERCISE | 80,000 | — | — |
| Mar 26, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 13,229 | $61.29 | $810.8K |
| Mar 26, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 2,485 | $61.29 | $152.3K |
| Mar 26, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 16,250 | — | — |
| Mar 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | EXERCISE | 18,750 | — | — |
| Mar 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 7,197 | — | — |
| Mar 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 2,384 | $76.35 | $182.0K |
| Mar 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 7,178 | $76.35 | $548.0K |
| Mar 15, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 3,815 | — | — |
| Mar 15, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | EXERCISE | 11,921 | — | — |
| Mar 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 3,678 | $86.75 | $319.1K |
| Mar 9, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | EXERCISE | 6,546 | — | — |
| Mar 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 2,462 | — | — |
| Mar 9, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 1,280 | $86.75 | $111.0K |
| Mar 6, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | AWARD | 1,986 | $88.11 | $175.0K |
| Mar 6, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | AWARD | 3,404 | $88.11 | $299.9K |
| Mar 4, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 1,424 | $77.63 | $110.5K |
| Mar 4, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | SELL | 5,861 | $77.63 | $455.0K |
| Mar 3, 2026 | Dechairo Bryan | Chief Operating Officer | AWARD | 10,430 | — | — |
| Mar 3, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | AWARD | 15,262 | — | — |
| Mar 3, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | AWARD | 10,865 | — | — |
| Mar 3, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | AWARD | 47,684 | — | — |
| Mar 3, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | AWARD | 40,418 | — | — |
| Mar 2, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | SELL | 287 | $77.52 | $22.2K |
| Mar 1, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | EXERCISE | 718 | — | — |
| Feb 4, 2026 | Dechairo Bryan | Chief Operating Officer | SELL | 779 | $83.04 | $64.7K |
6 SEC filing reports analyzed. Sentiment: 3 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 5.3/10.
BULLISH
INST-CLUSTER
4/10
A small institutional cluster of 5 buyers accumulated $15.3M in net new GeneDx stock during Q3 2024,
Jun 11, 2026
BULLISH
CLUSTER
6/10
GeneDx Holdings Corp. (WGS) insiders show a mixed cluster: Director/10% owner Casdin Capital made a
Jun 8, 2026
BULLISH
CLUSTER
6/10
Two large-position insiders at GeneDx (WGS) — Casdin Capital (a director/10% owner) and director Kei
May 20, 2026
BEARISH
CLUSTER
6/10
Analysis based on filing metadata only — document content was unavailable. Cross-filing context reve
Mar 30, 2026
BEARISH
CLUSTER
6/10
GeneDx CEO Katherine Stueland sold $455K in open-market shares while receiving a large non-cash stoc
Mar 9, 2026
NEUTRAL
CLUSTER
4/10
GeneDx CEO and CFO conducted open-market share sales totaling $587,754 over four days, while also re
Mar 5, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (92% buy). Based on 13 analysts: 4 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$77.00 mean target
+28.5% upside
Strong Buy (1.11)
$50.00 Low
$100.00 High
| Metric | Value |
|---|---|
| Current Price | $59.92 |
| Target Low | $50.00 |
| Target Mean | $77.00 |
| Target Median | $75.00 |
| Target High | $100.00 |
| # Analysts | 9 |
| Recommendation | Strong Buy (1.11) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.19 | $-0.30 | $-0.16 | -137.5% | -262.0% | 0↑ 6↓ | $0.1B | 8.1% | 8 |
| Next Q 2026-09-30 |
$0.12 | $-0.15 | $0.21 | -76.5% | -67.5% | 0↑ 5↓ | $0.1B | 8.0% | 8 |
| Current FY 2026-12-31 |
$0.11 | $-0.69 | $1.38 | -92.1% | -87.9% | 0↑ 2↓ | $0.5B | 11.9% | 8 |
| Next FY 2027-12-31 |
$1.23 | $0.41 | $2.37 | 1019.3% | -40.1% | 1↑ 5↓ | $0.6B | 24.4% | 8 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.188 | |
| 7d ago | $0.116 | -0.303 |
| 30d ago | $0.116 | -0.303 |
| 60d ago | $0.116 | -0.303 |
| 90d ago | $0.095 | -0.282 |
5 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 5, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 5, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| May 5, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 20, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Mar 30, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Feb 24, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Feb 24, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Feb 9, 2026 | Wells Fargo | UPGRADE | Equal-Weight | Overweight |
| Dec 22, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Dec 15, 2025 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| May 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Apr 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Mar 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 4 | 7 | 2 | 0 | 0 | 85% | |
| Jan 1, 2026 | 4 | 7 | 2 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
58°
Warm
Bearish
Neutral
Bullish
2 mentions
1 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jan 2, 2025 | 1 | 50° Neutral | 0 | 0 | 1 |
| Dec 6, 2024 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
06 MAY 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
▲ 1
💬 1
⚡ 0.2
WGS GeneDx stock
▲ 1
💬 1
⚡ 0.0
WGS GeneDx stock bullish, lets go!
▲ 1
💬 1
⚡ 0.0
May 19, 2026
short_volume
Short Volume: WGS — 62.8% short (0.3M / 0.5M)
Short: 320,518 | Exempt: 99 | TRF Vol: 510,219 | Short Ratio: 62.8% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: WGS — 61.2% short (0.4M / 0.6M)
Short: 391,299 | Exempt: 140 | TRF Vol: 639,215 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: WGS — 55.3% short (0.3M / 0.6M)
Short: 340,427 | Exempt: 0 | TRF Vol: 615,427 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)
May 14, 2026
short_volume
Short Volume: WGS — 64.3% short (0.4M / 0.6M)
Short: 387,425 | Exempt: 0 | TRF Vol: 602,973 | Short Ratio: 64.3% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_interest
FTD: WGS — 21,188 shares ($0.7M) failed to deliver
Settlement: 20260506, Price: $34.51, FTD Value: $731,197.88, GENEDX HLDGS CORP CL A NEW
May 5, 2026
short_volume
Short Volume: WGS — 57.8% short (3.2M / 5.5M)
Short: 3,164,006 | Exempt: 148,188 | TRF Vol: 5,475,918 | Short Ratio: 57.8% | Off-exchange volume (dark pool + OTC)
May 5, 2026
short_interest
FTD: WGS — 22,155 shares ($1.5M) failed to deliver
Settlement: 20260505, Price: $67.93, FTD Value: $1,504,989.15, GENEDX HLDGS CORP CL A NEW
May 4, 2026
earnings_calendar
WGS Q1 2026 Earnings Scheduled — 2026-05-04
Mar 30, 2026
short_volume
Short Volume: WGS — 59.0% short (0.3M / 0.6M)
Short: 342,914 | Exempt: 28,555 | TRF Vol: 581,076 | Short Ratio: 59.0% | Off-exchange volume (dark pool + OTC)
Feb 23, 2026
earnings_calendar
WGS Q4 2025 Earnings Before Market Open — 2026-02-23